ISO/TR 27507:2021 — Nanotechnologies — Risk Management Framework for Nanomaterials in Consumer Products

The incorporation of nanomaterials into consumer products — from cosmetics and textiles to food packaging and electronics — has grown exponentially over the past decade, bringing both functional benefits and potential safety concerns. ISO/TR 27507:2021 addresses this critical need by providing a dedicated risk management framework specifically tailored to nanomaterials in consumer products, recognising that consumer exposure scenarios differ fundamentally from occupational settings. This article provides a thorough technical analysis of the standard, its methodologies, and practical implementation strategies for product manufacturers and safety assessors.

Consumer-Specific Exposure Scenarios and Assessment

A cornerstone of ISO/TR 27507 is its detailed treatment of consumer exposure scenarios, which differ significantly from occupational exposures. Consumers typically face lower nanomaterial concentrations but over longer durations and through diverse routes — dermal, oral, inhalation, and ocular — often simultaneously. The standard categorises consumer products into use-pattern groups: rinse-off products (e.g., sunscreens, shampoos), leave-on products (e.g., creams, textiles), ingestible products (e.g., food additives, supplements), and inhalable products (e.g., sprays, powders). Each category requires a distinct exposure assessment approach, as the route of exposure, duration, frequency, and the physicochemical form of the nanomaterial (free particles, embedded in matrix, released during use) vary considerably.

The standard introduces a tiered exposure assessment framework. Tier 1 uses worst-case assumptions with conservative default values for exposure parameters, providing a screening-level assessment that is intentionally overprotective. If the Tier 1 assessment indicates acceptable risk, no further assessment is required. If not, Tier 2 employs more refined exposure models incorporating product-specific release factors, realistic usage patterns, and higher-tier in vitro or in vivo data. Tier 3, reserved for the most complex or high-exposure scenarios, involves probabilistic exposure modelling using Monte Carlo methods and biomonitoring studies to validate model predictions. This tiered approach ensures proportionality — simple products with low exposure potential are not burdened with excessive assessment requirements, while higher-risk products receive the scrutiny they warrant.

Hazard Communication and Safety Assessment

ISO/TR 27507 places strong emphasis on hazard communication throughout the supply chain, recognising that consumer product manufacturers often source nanomaterials from upstream suppliers and need reliable hazard information to perform their safety assessments. The standard recommends a structured data-sharing framework where suppliers provide comprehensive physicochemical characterisation data (particle size distribution, surface area, surface chemistry, crystal structure, solubility, and agglomeration state) along with standard toxicological data following OECD test guidelines adapted for nanomaterials.

For the safety assessment itself, the standard advocates a weight-of-evidence approach that integrates multiple data sources: physicochemical characterisation, in vitro toxicology (particularly using human-relevant cell models such as reconstructed human epidermis for dermal exposure and 3D lung models for inhalation), in vivo studies where necessary, in silico predictions (QSAR and grouping/read-across), and epidemiological evidence if available. The framework specifically addresses the challenge of assessing nanomaterial mixtures and complex formulations, which are common in consumer products but difficult to evaluate using standard single-substance approaches. A read-across justification framework is provided, enabling safety assessors to leverage data from well-characterised nanomaterials to assess similar materials with incomplete data sets.

Engineering Design Insights

From a product design perspective, ISO/TR 27507 encourages a “safe-by-design” approach that integrates safety considerations into the earliest stages of product development. Key design strategies for minimising consumer nanomaterial risk include: (1) immobilising nanoparticles within a solid or high-viscosity matrix to reduce release during use, (2) surface coating or encapsulation to reduce biological reactivity without compromising functional performance, (3) selecting biodegradable or soluble nanomaterials that clear from the body more rapidly, and (4) designing product packaging and instructions to minimise misuse that could lead to unexpected exposure. The standard also highlights the importance of post-market surveillance, recommending that manufacturers monitor adverse event reports, consumer complaints, and emerging scientific literature to identify potential safety issues that were not apparent during pre-market assessment.

A particularly valuable engineering insight from the standard relates to nanomaterial release testing. Many consumer products are claimed to be “nano-free” in terms of intentional addition, but nanomaterials can be released from bulk materials during use (e.g., nanoscale wear particles from textiles, nanocomposite degradation). ISO/TR 27507 recommends that release testing be conducted under simulated use conditions — including mechanical stress, UV exposure, and chemical degradation — to provide realistic exposure estimates for risk assessment.

Frequently Asked Questions